Venus concept receives fda 510(k) clearance for the venus freedom™

Toronto, oct. 19, 2021 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, today announced that it has received 510(k) clearance from the u.s. food and drug administration (“fda”) to market the venus freedom device in the united states.

VERO Ratings Summary

VERO Quant Ranking